Dexcom real-time continuous glucose monitoring (rt-CGM) systems are suitable for anyone with diabetes over the age of 2 years. Whether treated with multiple daily injections or insulin pump therapy, they can benefit real-time CGM.
Updated NICE Guidelines - Great news for access to real time CGM
NICE Guidelines for Adults
NICE now recommends that adults with type 1 diabetes are offered a choice of glucose sensor, including rt-CGM.3
Children & Young People
Real-time continuous glucose monitoring (rt-CGM) should be offered to all children and young people with type 1 diabetes.4
Type 2 diabetes
For people with insulin treated type 2 diabetes, NICE now recommends that rt-CGM can be considered as an alternative to isCGM (Intermittently Scanned Continuous Glucose Monitoring).5
Change the lives of people with diabetes. Choose Dexcom real-time CGM.
The range of Dexcom products allows you to offer access to real-time CGM to all people with diabetes, as recommended in the updated NICE guidelines.3,4,5
Dexcom ONE real-time CGM System
Best for people with T1 or T2 diabetes using insulin who are looking for an easy and accessible real-time CGM system available on prescription.
Dexcom G6 real-time CGM System
Best for people with T1 diabetes using a connected insulin dosing system.§
Dexcom G7 real-time CGM System
Best for people with T1 diabetes who may need extra support, such as people who are hypo unaware or children.
More Insight Than Monitoring Alone
Unlike a single reading from a blood glucose meter, real-time CGM provides dynamic information about the direction of glucose change, giving continuous and timely feedback on nutrition, activity, and insulin requirements to help make informed diabetes treatment decisions. Real-time CGM is a powerful therapy management tool that can inform better diabetes treatment decisions, ultimately leading to tighter glycaemic control, than using a blood glucose meter alone.1,||
Accessing Dexcom for Your Clinic
Updated NICE Guidelines - Great news for access to real time CGM
NICE Guidelines for Adults3
NICE now recommends that adults with type 1 diabetes are offered a choice of glucose sensor, including rt-CGM
Children and Young People4
Real-time continuous glucose monitoring (rt-CGM) should be offered to all children and young people with type 1 diabetes.
Type 2 diabetes5
For people with insulin treated type 2 diabetes, NICE now recommends that rt-CGM can be considered as an alternative to isCGM (intermittent scanning continuous glucose monitoring).
Dexcom is the offers a range of real-time CGM products tailored to the needs of all people with diabetes using insulin.
The Dexcom G6 was proven to be a highly cost-effective management option compared to finger sticking for T1D patients with elevated HbA1c levels. This falls well below the NICE willingness to pay threshold of £20,000 per QALY gained, at £9,558 per QALY gained. Based on the NHS funding criteria, it is estimated that up to 70% of patients with T1D may be eligible for the Dexcom G6.2,||
Please refer to the Diabetes UK. Type 1 Diabetes Technology: A Consensus Guideline for further details on identifying those that could benefit from real-time Continuous Glucose Monitoring (CGM) technology.
§ Compatible insulin-delivery device sold separately.
1 Pettus J et al. Endocr Pract. 2015; 21(6):613-620.
2 Roze S. et al. Diabetes Care. 2020; 43(10):2411-2417.
|| Results obtained with a prior generation Dexcom CGM system; similar results expected with Dexcom G7 given similar or better performance and enhanced feature sets and usability.
3 Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17]
5 Type 2 diabetes in adults: management NICE guideline [NG28]